成人国产精品一级毛片视频,毛片三级在线观看,中国黄色在线观看,婷婷久久综合九色综合九七,久久久免费视频观看,国产99在线播放,日本成人福利

產(chǎn)品分類導(dǎo)航
CPHI制藥在線 資訊 引領(lǐng)醫(yī)藥行業(yè)的數(shù)字科技 | Pharma Sources Insight第六期

引領(lǐng)醫(yī)藥行業(yè)的數(shù)字科技 | Pharma Sources Insight第六期

作者:PharmaSourcesInsig  來源:CPhI制藥在線
  2023-04-28
Your FREE source of news and insights into China pharmaceutical industry!

Pharma Sources Insight

       Pharma Sources Insight

       Your FREE source of news and insights into China pharmaceutical industry, and more!

掃碼開始閱讀 Scan to view the full contents.

掃碼開始閱讀

Scan to view the full contents.

Pharma Sources Insight

August 2021

       Pharma Sources Insight is a unique source of updated coverages on current events and deep insights into hot areas of the pharma industry, from China to the world. It follows up new developments with the leading drug-manufacturers in China which further affect the world.

       Now, join PharmaSources.com to get access to news of the Chinese pharmaceutical enterprises and to witness industrial changes through the exclusive perspectives of our expert writers into crucial aspects of the pharmaceutical field, all under PharmaSources.com and CPhI China.

 

       Pharma Sources Insight August 2021 focuses on the following topics:

       ?BRAND STORY

       -Product Lists of Nanjing Foreign Economic & Trade Development Co., Ltd.

       ?FIGHTING AGAINST 

          COVID-19

       -Which One of the New Dosage Forms of Nasal Spray Vaccine for COVID-19 Will Be Successful?

       -Overview of COVID-19 Vaccination in Progress in China

       -Having Applied for IPO to HKEX, What to Expect on Advaccine R&D Pipelines beyond COVID-19 DNA Vaccine

       -Science of Epidemiology: Digital Technologies Shaping Our Lives

       ?GLOBAL MARKET REVIEW

       -Alzheimer’s Disease - Recent Advances in Treatment

       -India’s Pharmaceutical Industry Disruption Impacts Africa and the World

       ?PHARMA IN CHINA

       -Popular Products and Suppliers at PharmaSources.com

       -Overseas Marketing of Furmonertinib Following Avitinib and Almonertinib

       -Bispecific Antibodies – Key Developments in China

       ?INDUSTRY INSIGHT

       -A Brief Introduction About FDA Next Step Inspections

往期回顧

August 2021

Pharma Sources Insight April 2021

第五期:https://flbook.com.cn/c/UvEylKXA3d

Pharma Sources Insight January2021

第四期:https://flbook.com.cn/c/hiKJryuATA

第二十一屆世界制藥原料中國展

相關(guān)文章

合作咨詢

   肖女士    021-33392297    Kelly.Xiao@imsinoexpo.com

2006-2025 上海博華國際展覽有限公司版權(quán)所有(保留一切權(quán)利) 滬ICP備05034851號-57
双鸭山市| 夏河县| 绩溪县| 杭州市| 获嘉县| 项城市| 明溪县| 平山县| 鲁山县| 新平| 绥芬河市| 高阳县| 苍南县| 通许县| 长海县| 葵青区| 安丘市| 南和县| 英吉沙县| 朔州市| 长武县| 洛隆县| 铜陵市| 黎城县| 平顶山市| 若羌县| 黔西| 河间市| 洛南县| 石泉县| 永顺县| 石首市| 佳木斯市| 上犹县| 中阳县| 洛川县| 宁远县| 独山县| 满洲里市| 汾西县| 邓州市|